Takeda Pharmaceuticals U.S.A., Inc. v. Dr. Reddy's Laboratories, Ltd.

Application Number	Patent Number	External Links
-	US7906519	Espacenet Google Patents
-	US7935731	Espacenet Google Patents
-	US8093298	Espacenet Google Patents
-	US7964648	Espacenet Google Patents
-	US8093297	Espacenet Google Patents

MOTION for Confidential Treatment of the Complaint and Its Exhibit A - filed by Takeda Pharmaceuticals U.S.A., Inc.. (mal) Modified on 6/24/2020 (nms). (Entered: 06/24/2020)

2020-06-24

1

View

DECLARATION of Thatcher A. Rahmeier re 1 MOTION for Confidential Treatment of the Complaint and Its Exhibit A, by Takeda Pharmaceuticals U.S.A., Inc.. (mal) Modified on 6/24/2020 (nms). (Entered: 06/24/2020)

2020-06-24

1

View

[SEALED] COMPLAINT filed with Jury Demand against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3015599.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A)(mal) (Additional attachment(s) added on 6/24/2020: # 2 Civil Cover Sheet, # 3 Civil Cover Sheet Case Related) (mal). (Entered: 06/24/2020)

2020-06-24

1

View

EXHIBITS B-K to 3 Complaint, by Takeda Pharmaceuticals U.S.A., Inc.. (mal) (Entered: 06/24/2020)

2020-06-24

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) (Entered: 06/24/2020)

2020-06-24

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519 ;7,935,731 ;8,093,298 ;7,964,648 ;8,093,297. (mal) (Entered: 06/24/2020)

2020-06-24

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc.. (mal) (Entered: 06/24/2020)

2020-06-24

1

View

ORDER Granting 1 MOTION for Confidential Treatment of the Complaint and Its Exhibit A. Signed by Judge Richard G. Andrews on 6/24/2020. (nms) (Entered: 06/24/2020)

2020-06-24

1

View

No Summons Issued. (mal)

2020-06-24

1

No Actions

Remark

2020-06-24

1

No Actions

No Summons Issued

2020-06-24

1

No Actions

Remark: Case submitted for routine judicial assignment. (mal)

2020-06-24

1

No Actions

Remark: Exit copies to Duty Judge (RGA) via email. (mal)

2020-06-24

1

No Actions

SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc.. Dr. Reddy's Laboratories, Ltd. served on 6/26/2020, answer due 7/17/2020. (DiGiovanni, Francis) (Entered: 06/29/2020)

2020-06-29

1

View

SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc.. Dr. Reddy's Laboratories, Inc. served on 6/26/2020, answer due 7/17/2020. (DiGiovanni, Francis) (Entered: 06/29/2020)

2020-06-29

1

View

Case Assigned/Reassigned

2020-07-01

1

No Actions

Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)

2020-07-01

1

No Actions

REDACTED VERSION of 3 Complaint, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Civil Cover Sheet Statement of Related Cases)(DiGiovanni, Francis) (Entered: 07/02/2020)

2020-07-02

1

View

- CORRECTING ENTRY

2020-07-02

1

No Actions

CORRECTING ENTRY: The redacted version of D.I. 3 filed at D.I. 11 has been removed from the docket as the filing was incomplete. D.I. 3 reflects that other attachments were included beyond Exhibit A. Counsel is to refile a complete redacted version of D.I. 3 . (nms)

2020-07-02

1

No Actions

CORRECTING ENTRY: The filing at D.I. 11 has been removed from the docket as it was not a mirror image of what is filed at D.I. 3 . Counsel is to refile a redacted version of D.I. 3 that is comprised of the Complaint, Exhibit A, the Civil Cover Sheet, and the Civil Cover Sheet Attachment. (nms)

2020-07-02

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming, Jonathan Herstoff and Camille Y. Turner of Haug Partners LLP - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) (Entered: 07/07/2020)

2020-07-07

1

View

SO ORDERED

2020-07-07

1

No Actions

SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming, Jonathan Herstoff and Camille Y. Turner of Haug Partners LLP, filed by Takeda Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 7/7/2020. (nms)

2020-07-07

1

No Actions

Add Attorneys - PHV only

2020-07-08

1

No Actions

Pro Hac Vice Attorneys Edgar H. Haug, Porter F. Fleming, Jonathan Herstoff, Camille Y. Turner for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)

2020-07-08

1

No Actions

[SEALED] ANSWER to 3 Complaint, with Jury Demand, COUNTERCLAIM against Takeda Pharmaceuticals U.S.A., Inc. by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Certificate of Service)(Brauerman, Stephen) (Entered: 07/17/2020)

2020-07-17

1

View

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Brauerman, Stephen) (Entered: 07/17/2020)

2020-07-17

1

View

- CORRECTING ENTRY

2020-07-17

1

No Actions

CORRECTING ENTRY: The Answer filed at D.I. 13 has been removed from the docket per counsel's request. A complete version of the Answer will be refiled. (nms)

2020-07-17

1

No Actions

Unopposed MOTION for Leave to File Answer, Defenses and Counterclaims Under Seal - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: # 1 Proposed Order)(Brauerman, Stephen) Modified on 7/22/2020 (nms). (Entered: 07/21/2020)

2020-07-21

1

View

ORDER Granting 15 Unopposed MOTION for Leave to File Answer, Defenses and Counterclaims Under Seal. Signed by Judge Richard G. Andrews on 7/22/2020. (nms) (Entered: 07/22/2020)

2020-07-22

1

View

REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 13 . (nms)

2020-07-28

1

No Actions

Deficiency re Redacted Documents

2020-07-28

1

No Actions

REDACTED VERSION of 13 Answer to Complaint,, Counterclaim, by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Brauerman, Stephen) (Entered: 07/29/2020)

2020-07-29

1

View

MOTION for Pro Hac Vice Appearance of Attorney Lana S. Shiferman - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: # 1 Certification)(Brauerman, Stephen) Modified on 8/3/2020 (nms). (Entered: 08/03/2020)

2020-08-03

1

View

SO ORDERED, re 18 MOTION for Pro Hac Vice Appearance of Attorney Lana S. Shiferman, filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 8/3/2020. (nms)

2020-08-03

1

No Actions

SO ORDERED

2020-08-03

1

No Actions

MOTION to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) Modified on 8/7/2020 (nms). (Entered: 08/07/2020)

2020-08-07

1

View

Unopposed Motion for Leave to File Opening Brief Under Seal - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Text Proposed Order)(Rahmeier, Thatcher) Modified on 8/7/2020 (nms). (Entered: 08/07/2020)

2020-08-07

1

View

[SEALED] OPENING BRIEF in Support re 19 MOTION to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims, filed by Takeda Pharmaceuticals U.S.A., Inc..Answering Brief/Response due date per Local Rules is 8/21/2020. (Rahmeier, Thatcher) Modified on 8/7/2020 (nms). (Entered: 08/07/2020)

2020-08-07

1

View

Deficiency Notice

2020-08-07

1

No Actions

DEFICIENCY NOTICE by the Court issued as to D.I. 21 re 21 Sealed Opening Brief in Support. A certificate of service was lacking from the filing. Counsel is referred to Local Rule 5.2(b). (nms)

2020-08-07

1

No Actions

CERTIFICATE OF SERVICE for Opening Brief in Support of Motion to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims (D.I. 21 ), by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) Modified on 8/10/2020 (nms). (Entered: 08/10/2020)

2020-08-10

1

View

Pro Hac Vice Attorney Lana S. Shiferman for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00792-RGA, 1:20-cv-00845-RGA(kmd)

2020-08-12

1

No Actions

Add Attorneys - PHV only

2020-08-12

1

No Actions

REDACTED VERSION of 21 Opening Brief in Support, by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) Modified on 8/13/2020 (nms). (Entered: 08/13/2020)

2020-08-13

1

View

ORDER Granting 20 Unopposed Motion for Leave to File Opening Brief Under Seal. Signed by Judge Richard G. Andrews on 8/17/2020. (nms) (Entered: 08/17/2020)

2020-08-17

1

View

Unopposed Motion to File Answering Brief Under Seal - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: # 1 Proposed Order)(Brauerman, Stephen) Modified on 8/24/2020 (nms). (Entered: 08/21/2020)

2020-08-21

1

View

[SEALED] ANSWERING BRIEF in Opposition re 19 MOTION to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..Reply Brief due date per Local Rules is 8/28/2020. (Attachments: # 1 Certificate of Service)(Brauerman, Stephen) (Entered: 08/21/2020)

2020-08-21

1

View

ORDER Granting 25 Unopposed Motion to File Answering Brief Under Seal. Signed by Judge Richard G. Andrews on 8/24/2020. (nms) (Entered: 08/24/2020)

2020-08-24

1

View

Unopposed Motion to File Reply Brief Under Seal - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Proposed Order)(Rahmeier, Thatcher) Modified on 8/28/2020 (nms). (Entered: 08/28/2020)

2020-08-28

1

View

[SEALED] REPLY BRIEF re 19 MOTION to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims filed by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) (Entered: 08/28/2020)

2020-08-28

1

View

REQUEST for Oral Argument by Takeda Pharmaceuticals U.S.A., Inc. re 19 MOTION to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims. (Rahmeier, Thatcher) (Entered: 08/28/2020)

2020-08-28

1

View

REDACTED VERSION of 26 Answering Brief in Opposition, by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Brauerman, Stephen) Modified on 8/31/2020 (nms). (Entered: 08/31/2020)

2020-08-31

1

View

ORDER Granting 28 Unopposed Motion to File Reply Brief Under Seal. Signed by Judge Richard G. Andrews on 8/31/2020. (nms) (Entered: 08/31/2020)

2020-08-31

1

View

REDACTED VERSION of 29 Reply Brief, by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) Modified on 9/1/2020 (nms). (Entered: 09/01/2020)

2020-09-01

1

View

STIPULATION and Proposed Order to Stay the Case by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) (Entered: 09/18/2020)

2020-09-18

1

View

SO ORDERED Granting 34 Stipulation and Order to Stay the Case. Signed by Judge Richard G. Andrews on 9/18/2020. (nms) (Entered: 09/18/2020)

2020-09-18

1

View

ORAL ORDER: In view of the stay entered on September 18, the pending motion (D.I. 19 ) is DISMISSED without prejudice to refiling when the stay is lifted. Ordered by Judge Richard G. Andrews on 9/21/2020. (nms) (Entered: 09/21/2020)

2020-09-21

1

View

Oral Order

2020-09-21

1

No Actions

ORDER Administratively Closing case (see Order for further details). Signed by Judge Richard G. Andrews on 9/22/2020. (nms) (Entered: 09/22/2020)

2020-09-22

1

View

Stipulation to EXTEND Time

2025-04-29

1

View

SO ORDERED AND ~Util - Set Deadlines

2025-04-30

1

No Actions

Stipulation to EXTEND Time

2025-05-14

1

View

Order AND ~Util - Set Deadlines

2025-05-15

1

View

Stipulation to EXTEND Time

2025-05-29

1

View

SO ORDERED

2025-05-29

1

No Actions

Stipulation of Dismissal

2025-06-02

1

View

Order AND ~Util - Terminate Civil Case

2025-06-17

1

View

Patent/Trademark Report to Commissioner of Patents

2025-06-18

1

View

Overview

Parties

Defendant

Dr. Reddy's Laboratories, Inc. Follow

Represented By

Dr. Reddy's Laboratories, Ltd. Follow

Represented By

Plaintiff

Takeda Pharmaceuticals U.S.A., Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

MOTION for Confidential Treatment of the Complaint and Its Exhibit A - filed by Takeda Pharmaceuticals U.S.A., Inc.. (mal) Modified on 6/24/2020 (nms). (Entered: 06/24/2020)

DECLARATION of Thatcher A. Rahmeier re 1 MOTION for Confidential Treatment of the Complaint and Its Exhibit A, by Takeda Pharmaceuticals U.S.A., Inc.. (mal) Modified on 6/24/2020 (nms). (Entered: 06/24/2020)

EXHIBITS B-K to 3 Complaint, by Takeda Pharmaceuticals U.S.A., Inc.. (mal) (Entered: 06/24/2020)

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) (Entered: 06/24/2020)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519 ;7,935,731 ;8,093,298 ;7,964,648 ;8,093,297. (mal) (Entered: 06/24/2020)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc.. (mal) (Entered: 06/24/2020)

ORDER Granting 1 MOTION for Confidential Treatment of the Complaint and Its Exhibit A. Signed by Judge Richard G. Andrews on 6/24/2020. (nms) (Entered: 06/24/2020)

No Summons Issued. (mal)

Remark

No Summons Issued

Remark: Case submitted for routine judicial assignment. (mal)

Remark: Exit copies to Duty Judge (RGA) via email. (mal)

SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc.. Dr. Reddy's Laboratories, Ltd. served on 6/26/2020, answer due 7/17/2020. (DiGiovanni, Francis) (Entered: 06/29/2020)

SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc.. Dr. Reddy's Laboratories, Inc. served on 6/26/2020, answer due 7/17/2020. (DiGiovanni, Francis) (Entered: 06/29/2020)

Case Assigned/Reassigned

Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)

REDACTED VERSION of 3 Complaint, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Civil Cover Sheet Statement of Related Cases)(DiGiovanni, Francis) (Entered: 07/02/2020)

- CORRECTING ENTRY

CORRECTING ENTRY: The redacted version of D.I. 3 filed at D.I. 11 has been removed from the docket as the filing was incomplete. D.I. 3 reflects that other attachments were included beyond Exhibit A. Counsel is to refile a complete redacted version of D.I. 3 . (nms)

CORRECTING ENTRY: The filing at D.I. 11 has been removed from the docket as it was not a mirror image of what is filed at D.I. 3 . Counsel is to refile a redacted version of D.I. 3 that is comprised of the Complaint, Exhibit A, the Civil Cover Sheet, and the Civil Cover Sheet Attachment. (nms)

MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming, Jonathan Herstoff and Camille Y. Turner of Haug Partners LLP - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) (Entered: 07/07/2020)

SO ORDERED

SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming, Jonathan Herstoff and Camille Y. Turner of Haug Partners LLP, filed by Takeda Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 7/7/2020. (nms)

Add Attorneys - PHV only

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Brauerman, Stephen) (Entered: 07/17/2020)

- CORRECTING ENTRY

CORRECTING ENTRY: The Answer filed at D.I. 13 has been removed from the docket per counsel's request. A complete version of the Answer will be refiled. (nms)

Unopposed MOTION for Leave to File Answer, Defenses and Counterclaims Under Seal - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: # 1 Proposed Order)(Brauerman, Stephen) Modified on 7/22/2020 (nms). (Entered: 07/21/2020)

ORDER Granting 15 Unopposed MOTION for Leave to File Answer, Defenses and Counterclaims Under Seal. Signed by Judge Richard G. Andrews on 7/22/2020. (nms) (Entered: 07/22/2020)

Deficiency re Redacted Documents

REDACTED VERSION of 13 Answer to Complaint,, Counterclaim, by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Brauerman, Stephen) (Entered: 07/29/2020)

MOTION for Pro Hac Vice Appearance of Attorney Lana S. Shiferman - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: # 1 Certification)(Brauerman, Stephen) Modified on 8/3/2020 (nms). (Entered: 08/03/2020)

SO ORDERED, re 18 MOTION for Pro Hac Vice Appearance of Attorney Lana S. Shiferman, filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 8/3/2020. (nms)

SO ORDERED

MOTION to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) Modified on 8/7/2020 (nms). (Entered: 08/07/2020)

Unopposed Motion for Leave to File Opening Brief Under Seal - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Text Proposed Order)(Rahmeier, Thatcher) Modified on 8/7/2020 (nms). (Entered: 08/07/2020)

[SEALED] OPENING BRIEF in Support re 19 MOTION to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims, filed by Takeda Pharmaceuticals U.S.A., Inc..Answering Brief/Response due date per Local Rules is 8/21/2020. (Rahmeier, Thatcher) Modified on 8/7/2020 (nms). (Entered: 08/07/2020)

Deficiency Notice

DEFICIENCY NOTICE by the Court issued as to D.I. 21 re 21 Sealed Opening Brief in Support. A certificate of service was lacking from the filing. Counsel is referred to Local Rule 5.2(b). (nms)

CERTIFICATE OF SERVICE for Opening Brief in Support of Motion to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims (D.I. 21 ), by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) Modified on 8/10/2020 (nms). (Entered: 08/10/2020)

Add Attorneys - PHV only

REDACTED VERSION of 21 Opening Brief in Support, by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) Modified on 8/13/2020 (nms). (Entered: 08/13/2020)

ORDER Granting 20 Unopposed Motion for Leave to File Opening Brief Under Seal. Signed by Judge Richard G. Andrews on 8/17/2020. (nms) (Entered: 08/17/2020)

Unopposed Motion to File Answering Brief Under Seal - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: # 1 Proposed Order)(Brauerman, Stephen) Modified on 8/24/2020 (nms). (Entered: 08/21/2020)

ORDER Granting 25 Unopposed Motion to File Answering Brief Under Seal. Signed by Judge Richard G. Andrews on 8/24/2020. (nms) (Entered: 08/24/2020)

Unopposed Motion to File Reply Brief Under Seal - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Proposed Order)(Rahmeier, Thatcher) Modified on 8/28/2020 (nms). (Entered: 08/28/2020)

[SEALED] REPLY BRIEF re 19 MOTION to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims filed by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) (Entered: 08/28/2020)

REQUEST for Oral Argument by Takeda Pharmaceuticals U.S.A., Inc. re 19 MOTION to Strike Certain Affirmative Defenses and Dismiss Both Counterclaims. (Rahmeier, Thatcher) (Entered: 08/28/2020)

REDACTED VERSION of 26 Answering Brief in Opposition, by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Brauerman, Stephen) Modified on 8/31/2020 (nms). (Entered: 08/31/2020)

ORDER Granting 28 Unopposed Motion to File Reply Brief Under Seal. Signed by Judge Richard G. Andrews on 8/31/2020. (nms) (Entered: 08/31/2020)

REDACTED VERSION of 29 Reply Brief, by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher) Modified on 9/1/2020 (nms). (Entered: 09/01/2020)

STIPULATION and Proposed Order to Stay the Case by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) (Entered: 09/18/2020)

SO ORDERED Granting 34 Stipulation and Order to Stay the Case. Signed by Judge Richard G. Andrews on 9/18/2020. (nms) (Entered: 09/18/2020)

ORAL ORDER: In view of the stay entered on September 18, the pending motion (D.I. 19 ) is DISMISSED without prejudice to refiling when the stay is lifted. Ordered by Judge Richard G. Andrews on 9/21/2020. (nms) (Entered: 09/21/2020)

Oral Order

ORDER Administratively Closing case (see Order for further details). Signed by Judge Richard G. Andrews on 9/22/2020. (nms) (Entered: 09/22/2020)

Stipulation to EXTEND Time

SO ORDERED AND ~Util - Set Deadlines

Stipulation to EXTEND Time

Order AND ~Util - Set Deadlines

Stipulation to EXTEND Time

SO ORDERED

Stipulation of Dismissal

Order AND ~Util - Terminate Civil Case

Patent/Trademark Report to Commissioner of Patents

Track Case Updates

Dr. Reddy's Laboratories, Inc.

Dr. Reddy's Laboratories, Ltd.

Takeda Pharmaceuticals U.S.A., Inc.